Hormone therapy after endometrial cancer
نویسندگان
چکیده
منابع مشابه
Hormone therapy after endometrial cancer.
Endometrial carcinoma is often listed in data sheets as an absolute contraindication to hormone replacement therapy. However, observational studies have not shown an increased rate of recurrence or mortality. Thus, it is often used after stage I or II disease. Alternatives such as progestogens, tibolone, raloxifene, venlafaxine and herbal preparations are examined. The use of progestogens is un...
متن کاملLong-term postmenopausal hormone therapy and endometrial cancer.
Estrogen-alone therapy (ET) or estrogen and progestin (EPT) as menopausal hormone therapy (HT) has been commonly used to alleviate menopausal symptoms. Treatments containing > or = 10 days per month of progestin are considered relatively safe with respect to endometrial cancer risk. However, the endometrial safety of long-term EPT regimens is uncertain. We conducted a case-control study of 311 ...
متن کاملResistance to chemotherapy and hormone therapy in endometrial cancer.
Endometrial cancer is the most common gynecological malignancy in developed countries and represents the eighth leading cause of cancer related death in women. The growing incidence of endometrial cancer leads scientists and oncologists to identify effective preventive measures and also molecular markers for diagnosis and prognosis. Chemotherapy and hormone therapy is the mainstay treatment opt...
متن کاملHormone therapy as a management strategy for lung metastasis after 5 years of endometrial cancer
RATIONALE Endometrial cancer patients with lung metastases are rare, and more rarely with long-term management of progesterone after recurrence. PATIENT CONCERNS Informed consent of the patients and their families. DIAGNOSES Endometrial cancer (IVB) (Refer to 2009 FIGO stag of endometrial cancer). INTERVENTIONS the patient was treated with Megestrol Acetate Dispersible Tablets (trade name...
متن کاملEndometrial cancer
کانسر آندومتر شایعترین بدخیمی دستگاه تناسلی زنان است، که تقریبا 7 درصد کانسرهای زنان را شامل می شود و چهارمین کانسر زنان بعد از کانسرهای (پستان، ریه و کلورکتال) در آمریکا است.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Menopause Society Journal
سال: 2003
ISSN: 1362-1807
DOI: 10.1258/136218003323010601